Literature DB >> 7689056

Histamine release from basophils in childhood: age dependency and inhibition by pertussis infection and pertussis toxin.

M Griese1, G Merkel, R Feldmann, I Bergfeld, D Reinhardt.   

Abstract

The influence of childhood pertussis infection and of purified pertussis toxin on histamine release from human basophil leucocytes was investigated. Three different stimuli, the peptide N-formyl-Met-Phe (NFMP), anti-IgE, and the calciumionophore A23187 were used to challenge the cells. When NFMP was the stimulus, histamine release in the control group (age 0.5-17 years) increased in an age-dependent fashion, whereas anti-IgE and A23187 stimulated release did not vary with age. During the convulsive state of pertussis infection there was a significant reduction of histamine release in response to 10 microM NFMP (from 9.5 +/- 1.4 [n = 21] to 6.7 +/- 1.5 [n = 19], P < 0.05) and in response to 800 and 80 U/ml anti-IgE (from 28.5 +/- 5 [n = 19] to 16.3 +/- 5 [n = 13], P < 0.05, and from 6.9 +/- 1.7 [n = 16] to 2 +/- 0.8 [n = 13], P < 0.01), whereas histamine release stimulated by A23187 was unchanged compared to release in control children. In vitro pretreatment of basophils from healthy children and adults with pertussis toxin also inhibited histamine release. When NFMP was the stimulus, release was completely blocked by pertussis toxin with an IC50 of about 11 ng/ml, whereas anti-IgE stimulated release was only inhibited by 20%-30% and release induced by A23187 was reduced to 40%-50% by toxin treatment. In conclusion we have demonstrated a functional impairment of histamine release during the convulsive state of pertussis and that this inhibition is likely to be mediated by pertussis toxin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689056     DOI: 10.1007/bf01954086

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  Biological characterization of "mast cell sensitizing" antibodies.

Authors:  I MOTA
Journal:  Life Sci (1962)       Date:  1963-07

2.  Pulmonary function in infants after pertussis.

Authors:  M Howenstine; H Eigen; R Tepper
Journal:  J Pediatr       Date:  1991-04       Impact factor: 4.406

3.  Respiratory morbidity and lung function after whooping-cough.

Authors:  I D Johnston; H R Anderson; H P Lambert; S Patel
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

4.  Sensitivity and specificity of clinical case definitions for pertussis.

Authors:  P A Patriarca; R J Biellik; G Sanden; D G Burstyn; P D Mitchell; P R Silverman; J P Davis; C R Manclark
Journal:  Am J Public Health       Date:  1988-07       Impact factor: 9.308

5.  Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release.

Authors:  M C Conroy; N F Adkinson; L M lichtenstein
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

6.  Histamine release test in comparison to standard tests in diagnosis of childhood allergic asthma.

Authors:  M Griese; G Kusenbach; D Reinhardt
Journal:  Ann Allergy       Date:  1990-07

7.  Action of pertussigen (pertussis toxin) on serum IgE and on Fc epsilon receptors on lymphocytes.

Authors:  J J Munoz; M G Peacock
Journal:  Cell Immunol       Date:  1990-05       Impact factor: 4.868

8.  Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma.

Authors:  V Casolaro; G Spadaro; G Marone
Journal:  Am Rev Respir Dis       Date:  1990-11

9.  Suppression of passive cutaneous anaphylaxis by pertussis toxin, an islet-activating protein, as a result of inhibition of histamine release from mast cells.

Authors:  T Nakamura; M Ui
Journal:  Biochem Pharmacol       Date:  1983-11-15       Impact factor: 5.858

10.  Human basophil releasability. I. Age-related changes in basophil releasability.

Authors:  G Marone; S Poto; L di Martino; M Condorelli
Journal:  J Allergy Clin Immunol       Date:  1986-02       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.